Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Actie Hageman factor: a plasma lysokinase of the human fibrinolytic system.

Literature DB >> 14450472

Actie Hageman factor: a plasma lysokinase of the human fibrinolytic system.

S G IATRIDIS, J H FERGUSON.

Abstract

Entities: Gene Species

Keywords: BLOOD COAGULATION; FIBRINOLYSIS

Mesh：

Substances：

Year: 1962 PMID： 14450472 PMCID： PMC291042 DOI： 10.1172/JCI104590

Source DB: PubMed Journal: J Clin Invest ISSN： 0021-9738 Impact factor: 14.808

× No keyword cloud information.

21 in total

1. Studies on the action of Hageman factor: evidence that activated Hageman factor in turn activates plasma thromboplastin antecedent.

Authors: O D RATNOFF; E W DAVIE; D L MALLETT
Journal: J Clin Invest Date: 1961-05 Impact factor: 14.808

2. Surface activation of plasma clotting: a function of Hageman factor.

Authors: C L JOHNSTON; J H FERGUSON; F A O'HANLON
Journal: Proc Soc Exp Biol Med Date: 1958-10

3. The role of Hageman factor in the initiation of blood coagulation.

Authors: R M HARDISTY; J MARGOLIS
Journal: Br J Haematol Date: 1959-04 Impact factor: 6.998

4. xi-Aminocaproic acid: an inhibitor of plasminogen activation.

Authors: N ALKJAERSIG; A P FLETCHER; S SHERRY
Journal: J Biol Chem Date: 1959-04 Impact factor: 5.157

5. Studies on the thrombolytic activity of human plasma.

Authors: W D SAWYER; A P FLETCHER; N ALKJAERSIN; S SHERRY
Journal: J Clin Invest Date: 1960-02 Impact factor: 14.808

6. Activation of plasminogen.

Authors: S MULLERTZ
Journal: Ann N Y Acad Sci Date: 1957-08-30 Impact factor: 5.691

7. On the production of plasma fibrinolytic activity within veins.

Authors: H C KWAAN; R LO; A J MCFADZEAN
Journal: Clin Sci Date: 1957-05 Impact factor: 6.124

8. Fibrinolysis in the organism.

Authors: T ASTRUP
Journal: Blood Date: 1956-09 Impact factor: 22.113

9. Fibrinolysokinase activity in animal and human tissue.

Authors: T ASTRUP; I STERNDORFF
Journal: Acta Physiol Scand Date: 1956-07-17

10. The fibrin plate method for estimating fibrinolytic activity.

Authors: T ASTRUP; S MULLERTZ
Journal: Arch Biochem Biophys Date: 1952-10 Impact factor: 4.013

19 in total

1. [THE SIGNIFICANCE OF PROTEOLYSIS IN OBSTETRICAL DEFIBRINATION HEMORRHAGES AND THERAPY WITH TRASYLOL].

Authors: D F STEICHELE; H J HERSCHLEIN
Journal: Arch Gynakol Date: 1964-04-14

2. The clinical assessment of fibrinolysis.

Authors: P T FLUTE
Journal: Proc R Soc Med Date: 1963-05

3. Structural changes accompanying enzymatic activation of human Hageman factor.

Authors: S D Revak; C G Cochrane; A R Johnston; T E Hugli
Journal: J Clin Invest Date: 1974-09 Impact factor: 14.808

Review 4. Anticoagulant and thrombolytic drugs. I. Patho-physiological and pharmacological aspects.

Authors: D Ogston; A S Douglas
Journal: Drugs Date: 1971 Impact factor: 9.546

5. Studies on a complex mechanism for the activation of plasminogen by kaolin and by chloroform: the participation of Hageman factor and additional cofactors.

Authors: D Ogston; C M Ogston; O D Ratnoff; C D Forbes
Journal: J Clin Invest Date: 1969-10 Impact factor: 14.808